Mathiesen O, Jacobsen L S, Holm H E, Randall S, Adamiec-Malmstroem L, Graungaard B K, Holst P E, Hilsted K L, Dahl J B
Department of Anaesthesia, Copenhagen University Hospital, Ndr. Ringvej, DK-2600 Glostrup, Denmark.
Br J Anaesth. 2008 Oct;101(4):535-41. doi: 10.1093/bja/aen215. Epub 2008 Jul 23.
Optimal pain treatment with minimal side-effects is essential for early mobility and recovery in patients undergoing total hip arthroplasty. We investigated the analgesic effect of pregabalin and dexamethasone in this surgical procedure.
One hundred and twenty patients were randomly allocated to either Group A (placebo), Group B (pregabalin 300 mg), or Group C (pregabalin 300 mg+dexamethasone 8 mg). The medication and acetaminophen 1 g were given before operation. Spinal anaesthesia was performed. Postoperative pain treatment was with acetaminophen 1 g three times daily and patient-controlled i.v morphine, 2.5 mg bolus. Nausea was treated with ondansetron. Morphine consumption, pain intensity at rest and during mobilization, nausea and vomiting, sedation, dizziness, and consumption of ondansetron were recorded 2, 4, and 24 h after operation. P<0.05 was considered statistically significant.
Twenty-four hour morphine consumption was significantly reduced in Groups B [mean (SD) 24 (14) mg] and C [25 (19) mg] compared with Group A [47 (28) mg]. Vomiting was reduced in Group C compared with Group B (P=0.03). Sedation was significantly increased in Group B compared with the other groups.
Pregabalin resulted in a 50% reduction in 24 h postoperative morphine requirements. This was not associated with a reduced incidence of nausea or vomiting. Pregabalin resulted in increased levels of sedation. Combining pregabalin and dexamethasone provided no additional effects on pain or opioid requirements.
对于接受全髋关节置换术的患者,采用副作用最小的最佳疼痛治疗方法对于早期活动和康复至关重要。我们研究了普瑞巴林和地塞米松在此手术过程中的镇痛效果。
120例患者被随机分为A组(安慰剂组)、B组(普瑞巴林300毫克)或C组(普瑞巴林300毫克+地塞米松8毫克)。术前给予药物和1克对乙酰氨基酚。实施脊髓麻醉。术后疼痛治疗为每日三次给予1克对乙酰氨基酚以及患者自控静脉注射吗啡,单次剂量2.5毫克。恶心用昂丹司琼治疗。记录术后2小时、4小时和24小时的吗啡用量、静息和活动时的疼痛强度、恶心和呕吐情况、镇静程度、头晕情况以及昂丹司琼的用量。P<0.05被认为具有统计学意义。
与A组[47(28)毫克]相比,B组[平均(标准差)24(14)毫克]和C组[25(19)毫克]的24小时吗啡用量显著减少。与B组相比,C组的呕吐情况有所减少(P=0.03)。与其他组相比,B组的镇静程度显著增加。
普瑞巴林使术后24小时吗啡需求量减少了50%。这与恶心或呕吐发生率的降低无关。普瑞巴林导致镇静水平升高。联合使用普瑞巴林和地塞米松对疼痛或阿片类药物需求量没有额外影响。